Archives

  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • 2019-06
  • 2018-07
  • 2-APB (2-aminoethoxydiphenyl borate): A Precision IP3R An...

    2026-03-27

    2-APB (2-aminoethoxydiphenyl borate): A Precision IP3R Antagonist for Calcium Signaling Research

    Executive Summary: 2-APB (2-aminoethoxydiphenyl borate, CAS 524-95-8) is a cell-permeable IP3 receptor antagonist that selectively inhibits Ins(1,4,5)P3-induced calcium release (IC50 = 42 μM in rat cerebellar microsomes) [APExBIO]. It is also an inhibitor of TRPC channels, including TRPC3 (IC50 = 20 μM), TRPC5, and TRPC6, expanding its utility in channel modulation studies [CaChannelBlockers]. 2-APB blocks store-operated calcium entry (SOCE), calcium oscillations, and waves, which are crucial for intracellular signaling [B-amyloid10-35]. Its proven value in oxidative stress and apoptosis research is supported by animal models showing antioxidative and antiapoptotic effects at 2–4 mg/kg i.p. (Cheng et al., 2026). 2-APB is not water-soluble, but dissolves in ethanol (≥27.85 mg/mL) and DMSO (≥9.4 mg/mL).

    Biological Rationale

    Intracellular calcium (Ca2+) signaling is a fundamental process in eukaryotic cell function. The inositol 1,4,5-trisphosphate receptor (IP3R) mediates Ca2+ release from the endoplasmic reticulum (ER), directly impacting processes such as autophagy, apoptosis, and oxidative stress response [Cheng et al., 2026]. Starvation and other stressors modulate ER Ca2+ handling, altering the balance between autophagy (energy conservation and cell survival) and apoptosis (programmed cell death) [CEP-32496]. Aberrant Ca2+ oscillations and waves are implicated in diverse pathologies, including ischemia-reperfusion injury and neurodegeneration. IP3R-mediated Ca2+ fluxes are central to these processes, making selective pharmacological inhibition a powerful research tool.

    Mechanism of Action of 2-APB (2-aminoethoxydiphenyl borate)

    2-APB is a synthetic, cell-permeable small molecule that antagonizes IP3R on the ER membrane, thereby inhibiting Ins(1,4,5)P3-induced Ca2+ release [APExBIO]. At micromolar concentrations (10–100 μM), 2-APB effectively blocks IP3-mediated Ca2+ mobilization in a variety of cell types [CaChannelBlockers]. It also inhibits store-operated Ca2+ entry (SOCE) and several transient receptor potential canonical (TRPC) channels, notably TRPC3, TRPC5, and TRPC6 [B-amyloid10-35]. In the context of the ER-Ca2+-calpain pathway, 2-APB suppresses Ca2+ efflux, thereby modulating downstream effectors such as calpains and caspase-3 [Cheng et al., 2026]. This dual action—blocking both IP3R and TRPC channels—enables precise experimental control over intracellular Ca2+ dynamics.

    Evidence & Benchmarks

    • 2-APB inhibits Ins(1,4,5)P3-induced Ca2+ release in rat cerebellar microsomes with an IC50 of 42 μM (pH 7.2, 37°C) (APExBIO).
    • It blocks TRPC3 and TRPC5 channel activity in HEK-293 cells with IC50 values of 20 μM and 20 μM, respectively (B-amyloid10-35).
    • Suppresses starvation-induced calcium signaling, autophagy (LC3-II, ATG5 expression), and apoptosis (caspase-3 activation) in Bombyx mori fat body explants in vitro and in vivo (Cheng et al., 2026).
    • Reduces DNA fragmentation, increases superoxide dismutase and glutathione levels in rat models of ischemia-reperfusion injury at 2–4 mg/kg i.p. (APExBIO).
    • Effectively blocks store-operated Ca2+ entry (SOCE) in cultured mammalian cells at 20–100 μM (CEP-32496).

    For a focused review on the ER-Ca2+-calpain signaling axis, see "2-APB as a Precision Tool for ER-Ca2+-Calpain Pathway Research", which this article extends by presenting quantitative in vivo benchmarks and updated cross-species insights.

    Applications, Limits & Misconceptions

    2-APB is used extensively in cell signaling research to dissect IP3-mediated Ca2+ release, SOCE, and TRPC channel function. Typical applications include:

    • Analysis of autophagy and apoptosis transitions in response to ER Ca2+ fluxes (Cheng et al., 2026).
    • Oxidative stress-related cell injury models, especially ischemia-reperfusion paradigms (APExBIO).
    • Dissection of TRPC channel contributions to store-operated Ca2+ entry (B-amyloid10-35).

    Compared to previous reviews (e.g., CaChannelBlockers), this article provides comprehensive cross-application benchmarks, including quantitative IC50 values in diverse systems.

    Common Pitfalls or Misconceptions

    • 2-APB is not selective for IP3R at high concentrations; it also inhibits SOCE and TRPC channels, potentially confounding pathway attribution (CEP-32496).
    • It is insoluble in water; improper dissolution can result in precipitation and loss of activity (APExBIO).
    • Long-term storage of 2-APB in solution is not recommended due to degradation; prepare fresh aliquots for each experiment (APExBIO).
    • It should not be used in clinical or diagnostic settings; for research use only (APExBIO).
    • Some cell types may have variable sensitivity; empirical titration is advised before experimental use (B-amyloid10-35).

    Workflow Integration & Parameters

    2-APB is supplied as a solid by APExBIO (SKU: B6643) and should be stored at room temperature. It is soluble in ethanol (≥27.85 mg/mL) and DMSO (≥9.4 mg/mL) but insoluble in water. Typical working concentrations in cell culture range from 10–100 μM. For animal models, intraperitoneal doses of 2–4 mg/kg have demonstrated antioxidative and antiapoptotic effects in ischemia-reperfusion injury studies (Cheng et al., 2026). Solutions should be freshly prepared and used immediately. For details on the B6643 kit and ordering, refer to the APExBIO product page.

    For a broader perspective on the mechanism and selectivity of 2-APB, see "2-APB: A Selective IP3R Antagonist for Calcium Signaling". This article updates that review with new quantitative in vivo data and critical workflow notes for reproducibility.

    Conclusion & Outlook

    2-APB (2-aminoethoxydiphenyl borate) provides selective, reproducible inhibition of IP3R-mediated and TRPC channel-dependent Ca2+ mobilization. Its robust performance in both in vitro and in vivo models has established it as a cornerstone reagent for cell signaling, oxidative stress, and apoptosis research. Ongoing studies continue to refine its use, highlighting its value for dissecting the ER-Ca2+-calpain axis, autophagy-apoptosis transitions, and SOCE-related processes. Researchers are encouraged to validate concentrations and solubilization protocols for each new system. For more details, see the full specifications and ordering information for 2-APB (2-aminoethoxydiphenyl borate) B6643 from APExBIO.